0.0497	2.3777	OMIM:182980	SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	VAPB	9217
0.0497	2.3015	OMIM:300695	#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	FHL1	2273
0.0497	2.0264	OMIM:310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE	DMD	1756
0.0931	2.2609	OMIM:601419	#601419 MYOPATHY, MYOFIBRILLAR, 1; MFM1;;MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED;;DESMINOPATHY, PRIMARY;;DESMIN-RELATED MYOPATHY; DRM;;INCLUSION BODY MYOPATHY 1, AUTOSOMAL DOMINANT, FORMERLY; IBM1, FORMERLY;;CARDIOMYOPATHY, DILATED, 1F AND LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE1D, FORMERLY;;CMD1F AND LGMD1D, FORMERLY;;CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT AND MUSCULAR DYSTROPHY;CDCD3, FORMERLY	DES	1674
0.1490	2.0858	OMIM:611615	CARDIOMYOPATHY, DILATED, 1X	FKTN	2218
0.1490	2.0283	OMIM:300257	#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIB; GSD2B, FORMERLY;;GSD IIB, FORMERLY	LAMP2	3920
0.1552	2.5542	OMIM:613688	#613688 LONG QT SYNDROME 2; LQT2LONG QT SYNDROME 2, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/5, DIGENIC, INCLUDED; LQT2/5, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/9, DIGENIC, INCLUDED; LQT2/9, DIGENIC, INCLUDED	KCNH2	3757
0.1552	2.5542	OMIM:603830	#603830 LONG QT SYNDROME 3; LQT3LONG QT SYNDROME 3, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;;LONG QT SYNDROME 3/6, DIGENIC, INCLUDED; LQT3/6, DIGENIC, INCLUDED	SCN5A	6331
0.1552	2.5542	OMIM:613693	#613693 LONG QT SYNDROME 6; LQT6LONG QT SYNDROME 6, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 3/6, DIGENIC, INCLUDED; LQT3/6, DIGENIC, INCLUDED	KCNE2	9992
0.1552	2.5542	OMIM:613695	#613695 LONG QT SYNDROME 5; LQT5LONG QT SYNDROME 5, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 2/5, DIGENIC, INCLUDED; LQT2/5, DIGENIC, INCLUDED	KCNE1	3753
0.1552	2.0300	OMIM:300376	#300376 MUSCULAR DYSTROPHY, BECKER TYPE; BMD;;BECKER MUSCULAR DYSTROPHY;;MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, BECKER TYPE	DMD	1756
0.1552	1.9875	OMIM:300717	#300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	FHL1	2273
0.1834	2.6099	OMIM:613507	#613507 GLYCOGEN STORAGE DISEASE XV; GSD15;;GSD XV;;GLYCOGENIN DEFICIENCY;;GYG1 DEFICIENCY	GYG1	2992
0.1837	2.0015	OMIM:232300	GLYCOGEN STORAGE DISEASE II	GAA	2548
0.1837	1.8406	OMIM:608627	#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	VAPB	9217
0.1840	2.2425	OMIM:192500	#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	KCNQ1	3784
0.1840	1.8517	OMIM:253300	SPINAL MUSCULAR ATROPHY, TYPE I	SMN1	6606
0.2028	2.1158	OMIM:614302	#614302 EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7	TMEM43	79188
0.2160	1.8516	OMIM:613158	#613158 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2N; LGMD2N;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED	POMT2	29954
0.2160	1.6055	OMIM:614932	#614932 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	PNPT1	87178
